1. Methyllucidone may have a neuroprotective potential via inhibition of neurotoxic microglial activation implicated in neurodegeneration.
|CFN98507||Ginkgolic acid C13:0
1.Ginkgolic acid C13:0 exhibits the highest α-glucosidase inhibitory activity.
1. Bergenin has antiviral and antifungal activities.
2. Bergenin has antiarrhythmic and antitumor activities.
3. Bergenin has antiinflammatory and potent immunomodulatory activities.
4. Bergenin has antitussive, antiulcerogenic,anti-plasmodial, anti-hepatotoxic and wound healing activities.
5. Bergenin has antidiabetic activity, could be classified as a new group of α-glucosidase inhibitors.
6. Bergenin has a potential anti-narcotic effect via regulation of GSH contents and oxidative stress.
7. Bergenin reduces the expression of NO, TNF-α, IL-1β, and IL-6 proinflammatory cytokines by inhibiting the activation of the NF-κB and MAPKs signaling pathways, and it may represent a novel treatment strategy for mastitis.
1. 9,13β-Epidioxy-8(14)-abieten-18-oic acid exhibits moderate activities on NO levels in LPS-stimulated murine microglia BV2 cells, with IC50 values of 57.3 ± 0.2 uM, suggests that it has anti-inflammatory activities.
2. 9α,13α-Epidioxyabiet-8(14)-en-18-oic acid shows potent inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate, suggests that it is a potential antitumor-promoting diterpenoid.
3. 9 α ,13 β -Epidioxyabeit-8(14)en-18-oic acid may contribute to the growth inhibitory effect of the pine needles and may play an important role in the allelopathy of red pine.
Xanthobaccin A produced by strain SB-K88 plays a key role in suppression of sugar beet damping-off disease.